Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$640M Buy
4,556,244
+2,962,203
+186% +$387M 0.47% 25
2014
Q2
$189M Buy
1,594,041
+18,604
+1% +$2.15M 0.15% 163
2014
Q1
$194M Sell
1,575,437
-9,753
-0.6% -$1.18M 0.17% 134
2013
Q4
$181M Buy
1,585,190
+579
+0% +$65.9K 0.17% 140
2013
Q3
$177M Buy
1,584,611
+318,459
+25% +$34.5M 0.18% 123
2013
Q2
$125M Buy
+1,266,152
New +$131M 0.15% 149

Other funds holding AMGN

UBS's AMGN Position: Q3 2014 in Review

UBS increased its Amgen (AMGN) stake by 186% in Q3 2014, buying an estimated $387M and bringing the position to 4,556,244 shares worth $640M. The position accounts for 0.47% of the portfolio, ranked #25.

UBS first reported a position in AMGN in Q2 2013 and has held it in 6 quarters since. 1,222 funds tracked by Wall St. Rank hold AMGN as of Q3 2014.

  • UBS held 4,556,244 shares of Amgen worth $640M as of Q3 2014.
  • UBS bought 2,962,203 Amgen shares in Q3 2014, an estimated $387M.
  • Amgen made up 0.47% of UBS's portfolio in Q3 2014, its #25 holding.
  • UBS first reported a position in Amgen in Q2 2013 and has held it in 6 quarters since.
  • 1,222 funds tracked by Wall St. Rank held Amgen as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.